Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/26 16:05 | 2/2/26 | AMLX | Health | Drug | Pharmaceutical Preparations | Frates James M | MA | O | CFO | 2 | S | -89 | 12.94 | 0 | -7 | 304 | D | |||||||||||||||
2/4/26 16:05 | 2/2/26 | AMLX | Health | Drug | Pharmaceutical Preparations | Cohen Joshua B | MA | DO | Co-CEO | 4 | S.dm | -3,705 | 10.25 | 0 | -361 | 3,379 | D | |||||||||||||||
2/4/26 16:05 | 2/2/26 | AMLX | Health | Drug | Pharmaceutical Preparations | Mazzariello Gina | MA | O | GC | 1 | S | -51 | 14.65 | 0 | -3 | 145 | D | |||||||||||||||
2/4/26 16:05 | 2/2/26 | AMLX | Health | Drug | Pharmaceutical Preparations | Klee Justin B. | MA | DO | Co-CEO | 4 | S.dm | -3,705 | 10.25 | 0 | -361 | 3,379 | D | |||||||||||||||
12/23/25 20:48 | 12/23/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Firestone Karen | MA | D | 1 | P | 101 | 12.45 | 0 | 8 | 15 | 63 | D | |||||||||||||||
12/3/25 16:39 | 12/1/25 | AMLX | Health | Drug | Pharmaceutical Preparations | Bedrosian Camille L | MA | O | Chief Me | 1 | S | -94 | 14.35 | 0 | -7 | 176 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |